Spruce Biosciences Raises $88 Million in Series B ... - Business Wire
Feb 20, 2020 · SAN FRANCISCO--(BUSINESS WIRE)--Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …
OFF
Spruce Biosciences Raises $88 Million In Series B ... - Business Wire
6 days from now
Feb 20, 2020 · SAN FRANCISCO--(BUSINESS WIRE)--Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …
businesswire.com
OFF
Spruce Biosciences Raises $88 Million In Series B Financing
6 days from now
Feb 20, 2020 · Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications
biospace.com
OFF
Wilson Sonsini Advises Spruce Biosciences On IP Matters Related …
6 days from now
On February 19, 2020, Spruce Biosciences, a clinical stage biopharmaceutical company developing therapeutics for rare endocrine diseases, announced it has raised $88 million in …
wsgr.com
OFF
Omega Funds Co-leads Spruce Biosciences' $88M Series B
6 days from now
Feb 19, 2020 · Gunderson Dettmer client Omega Funds co-led the $88 million Series B financing of Spruce Biosciences, a bio-pharmaceutical company developing novel therapies for rare …
gunder.com
OFF
Trusted Insight | Spruce Biosciences Raises $88M In Series B …
6 days from now
SAN FRANCISCO, February 20, 2020-- Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and supported by …
thetrustedinsight.com
OFF
Spruce Biosciences Closes On $88 Million Series B Round
6 days from now
Feb 20, 2020 · Spruce intends to use the funds raised to evaluate tildacerfont to reduce glucocorticoid steroid usage in adults with CAH, and to complete proof-of-concept trials in …
biospace.com
OFF
Series B - Spruce Biosciences - 2020-02-20 - Crunchbase
6 days from now
Feb 20, 2020 · Spruce Biosciences raised $88000000 on 2020-02-20 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Business Wire — Spruce …
crunchbase.com
OFF
Spruce Biosciences Reports Second Quarter 2022 ... - Business Wire
6 days from now
Aug 10, 2022 · Research and Development (R&D) Expenses: R&D expenses for the three and six months ended June 30, 2022, were $9.1 million and $17.6 million, respectively, compared to …
businesswire.com
OFF
Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …
6 days from now
San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …
sprucebio.com
OFF
Spruce Biosciences, Inc. (SPRB) - Yahoo Finance
6 days from now
3.3600. -0.88%. PRAX Praxis Precision Medicines, Inc. 82.97. -2.19%. Find the latest Spruce Biosciences, Inc. (SPRB) stock quote, history, news and other vital information to help you …
yahoo.com
OFF
Spruce Biosciences, Inc. (SPRB) - Stock Analysis
6 days from now
Analyst Forecast. According to 7 analysts, the average rating for SPRB stock is "Hold." The 12-month stock price forecast is $2.5, which is an increase of 389.05% from the latest price. Price …
stockanalysis.com
OFF
Spruce Biosciences Raises $88 Million In Series B Financing, Co …
6 days from now
Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth February 19, 2020 Proceeds to advance development of Tildacerfont in Congenital …
sprucebio.com
OFF
Spruce Biosciences Reports Fourth Quarter And Full Year
6 days from now
Mar 14, 2022 · Net Loss: Net loss for the fourth quarter and full year ended December 31, 2021 was $9.2 million and $42.3 million, respectively, compared to $8.3 million and $29.5 million for …
businesswire.com
OFF
Spruce Biosciences Reports First Quarter 2021 Financial Results …
6 days from now
Presentation of Phase 2 Data of Tildacerfont at 23 rd Annual European Congress of Endocrinology . Cash and Cash Equivalents of $148.6 million. SAN FRANCISCO- …
sprucebio.com
OFF
Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …
6 days from now
San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …
healthcap.eu
FAQs about Spruce Biosciences Raises $88 Million in Series B ... - Business Wire Coupon?
What does Spruce Biosciences specialize in?
Is spruce Biosciences being investigated for securities fraud?
Does spruce Biosciences own tildacerfont?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
